Gitte Moos Knudsen, Professor, Chief Neurologist, DMSc, Neurobiology Research Unit (NRU), Rigshospitalet and University of Copenhagen (UCPH), Denmark.
Director of the Lundbeck Foundation Cimbi (2006-17), Innovation Fund Center NeuroPharm (2016-).
Present appointments: Chief neurologist at Dept Neurology and chairman at the Neurobiology Research Unit (NRU), Rigshospitalet, and Director of Center for Experimental Medicine Neuropharmacology (NeuroPharm). Professor in Clinical Neurobiology at the Univ. Copenhagen. President of the European College of Neuropsychopharmacology.
Research focus: I am a translational neurobiologist and clinical neurologist with interest in advanced methodological developments that I subsequently apply in my research to address pertinent neurobiological and clinical issues. I have a particular focus on multimodality neuroimaging of pharmacological effects in large animals, in healthy individuals and in patients with brain disorders.
Why do the effects of some psychedelics last 10 hours, while others are over within minutes? Gitte Moos Knudsen is a translational neurobiologist and clinical neurologist with a large track record of research into serotonin 2A receptors. She will speak at ICPR on the reasons for long- or short-acting psychedelics, the future development of possible specific psychedelics, and what this will mean for future research and development.